West Pharmaceutical Services Research and Development Expenses 2010-2023 | WST

West Pharmaceutical Services annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • West Pharmaceutical Services research and development expenses for the quarter ending December 31, 2023 were $0.018B, a 15.72% increase year-over-year.
  • West Pharmaceutical Services research and development expenses for the twelve months ending December 31, 2023 were $0.068B, a 16.92% increase year-over-year.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.
  • West Pharmaceutical Services annual research and development expenses for 2021 were $0.053B, a 12.58% increase from 2020.
West Pharmaceutical Services Annual Research and Development Expenses
(Millions of US $)
2023 $68
2022 $59
2021 $53
2020 $47
2019 $39
2018 $40
2017 $39
2016 $37
2015 $34
2014 $37
2013 $38
2012 $33
2011 $29
2010 $24
2009 $20
West Pharmaceutical Services Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $18
2023-09-30 $16
2023-06-30 $17
2023-03-31 $17
2022-12-31 $16
2022-09-30 $14
2022-06-30 $14
2022-03-31 $15
2021-12-31 $14
2021-09-30 $13
2021-06-30 $14
2021-03-31 $12
2020-12-31 $13
2020-09-30 $13
2020-06-30 $11
2020-03-31 $11
2019-12-31 $10
2019-09-30 $9
2019-06-30 $10
2019-03-31 $10
2018-12-31 $10
2018-09-30 $10
2018-06-30 $11
2018-03-31 $10
2017-12-31 $10
2017-09-30 $9
2017-06-30 $10
2017-03-31 $10
2016-12-31 $10
2016-09-30 $9
2016-06-30 $9
2016-03-31 $9
2015-12-31 $10
2015-09-30 $9
2015-06-30 $8
2015-03-31 $8
2014-12-31 $8
2014-09-30 $10
2014-06-30 $10
2014-03-31 $10
2013-12-31 $10
2013-09-30 $10
2013-06-30 $10
2013-03-31 $9
2012-12-31 $9
2012-09-30 $8
2012-06-30 $8
2012-03-31 $8
2011-12-31 $7
2011-09-30 $8
2011-06-30 $7
2011-03-31 $7
2010-12-31 $7
2010-09-30 $6
2010-06-30 $6
2010-03-31 $5
2009-12-31 $6
2009-09-30 $5
2009-06-30 $5
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.631B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.158B 20.25
Becton Dickinson (BDX) United States $67.917B 19.22
Cardinal Health (CAH) United States $23.884B 13.66
Align Technology (ALGN) United States $21.108B 40.75
Cooper (COO) United States $18.820B 28.48
Labcorp (LH) United States $17.378B 14.96
Henry Schein (HSIC) United States $9.436B 16.73
DENTSPLY SIRONA (XRAY) United States $5.855B 15.16
Merit Medical Systems (MMSI) United States $4.655B 25.51
Patterson (PDCO) United States $2.356B 11.29
CONMED (CNMD) United States $2.167B 19.65
STAAR Surgical (STAA) United States $2.106B 80.87
Atrion (ATRI) United States $0.753B 38.78
Lifevantage (LFVN) United States $0.086B 11.15
Pro-Dex (PDEX) United States $0.063B 31.81
Biolase (BIOL) United States $0.006B 0.00